Matthew J White Form 4 LINDE / Matthew J White ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

White Matthew J

(Last) (First) (Middle)

C/O LINDE PLC

THE PRIESTLEY CENTRE, 10 PRIESTLEY ROAD

(Street)

GUILDFORD, SURREY X0 GU2 7XY

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/01/2019

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares								2,960.295	I	401 (k)
Ordinary Shares	02/01/2019		M		20,290(1)	A	$60.92	36,901	D
Ordinary Shares	02/01/2019		F		12,541(2)	D	$165	24,360	D
Orinary Shares	02/01/2019		S		7,749	D	$164.99	16,611	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0(3)							(3)	(3)	Ordinary Shares	7,765		7,765	D
Restricted Stock Units	$0(4)							(4)	(4)	Ordinary Shares	6,054		6,054	D
Restricted Stock Units	$0(5)							(5)	(5)	Ordinary Shares	7,960		7,960	D
Restricted Stock Units	$0(4)							(4)	(4)	Ordinary Shares	6,191		6,191	D
Restricted Stock Units	$0(5)							(5)	(5)	Ordinary Shares	5,450		5,450	D
Stock Option (right to buy)	$60.92	02/01/2019		M			20,290	02/24/2010(6)	02/24/2019	Ordinary Shares	20,290	$0	0	D
Stock Option (right to buy)	$76.16							02/23/2011(6)	02/23/2020	Ordinary Shares	13,640		13,640	D
Stock Option (right to buy)	$97.84							02/22/2012(6)	02/22/2021	Ordinary Shares	14,845		14,845	D
Stock Option (right to buy)	$109.68							02/28/2013(6)	02/28/2022	Ordinary Shares	18,430		18,430	D
Stock Option (right to buy)	$110.58							02/26/2014(6)	02/26/2023	Ordinary Shares	15,060		15,060	D
Stock Option (right to buy)	$128.8							02/25/2015(6)	02/25/2024	Ordinary Shares	31,090		31,090	D
Stock Option (right to buy)	$128.38							02/24/2016(6)	02/24/2025	Ordinary Shares	40,865		40,865	D
Stock Option (right to buy)	$102.22							02/23/2017(7)	02/23/2026	Ordinary Shares	85,205		85,205	D
Stock Option (right to buy)	$118.71							02/28/2018(8)	02/28/2027	Ordinary Shares	72,795		72,795	D
Stock Option (right to buy)	$154							02/27/2019(9)	02/27/2028	Ordinary Shares	64,665		64,665	D
Deferred Stock Units	$0(10)							(11)	(11)	Ordinary Shares	732.164		732.164	D

Explanation of Responses:

1. This Stock Option was exercized pursuant to a Rule 10b 5-1 Plan dated November 21, 2018

2. Shares withheld from option exercise to pay exercise price and taxes.

3. Restricted Stock Units that will vest in full and payout on February 27,2021 in Linde plc Ordinary Shares on a one-for-one bases

4. Restricted Stock Units that will vest in full and payout on February 23, 2019 in Linde plc Ordinary Shares on a one-for-one basis.

5. Restricted Stock Units that will vest in full and payout on February 28, 2020 in Linde plc Ordinary Shares on a one-for-one basis.

6. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.

7. This option vests over three years in three consecutive equal annual installments beginning on February 23, 2017.

8. This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018.

9. This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019.

10. Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.

11. Deferred stock units previously acquired under Praxair, Inc.'s Compensation Deferral Plan ("Deferral Plan") that will be converted and paid out in Linde plc ordinary share on a one-for-one basis.

Remarks:

	Anthony M. Pepper, Attorney-in-Fact	02/05/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.